1.

Additional file 1 of Barriers, facilitators and solutions for active inclusive play for children with a physical disability in the Netherlands: a qualitative study

1.

Additional file 2 of Barriers, facilitators and solutions for active inclusive play for children with a physical disability in the Netherlands: a qualitative study

1.

Additional file 3 of Barriers, facilitators and solutions for active inclusive play for children with a physical disability in the Netherlands: a qualitative study

1.

Additional file 4 of Barriers, facilitators and solutions for active inclusive play for children with a physical disability in the Netherlands: a qualitative study

1.

Additional file 5 of Barriers, facilitators and solutions for active inclusive play for children with a physical disability in the Netherlands: a qualitative study

1.

Decolonisation initiatives at the Institute of Tropical Medicine, Antwerp, Belgium: ready for change?

2.

Decolonisation initiatives at the Institute of Tropical Medicine, Antwerp, Belgium: ready for change?

3.

Decolonisation initiatives at the Institute of Tropical Medicine, Antwerp, Belgium: ready for change?

1.

Living with facioscapulohumeral muscular dystrophy during the first two COVID-19 outbreaks: a repeated patient survey in the Netherlands

1.

Supplementary Material for: Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium ....

2.

Supplementary Material for: Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium ....

3.

Supplementary Material for: Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium ....

1.

Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium.

1.

Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium